Shape Therapeutics Company
A biotechnology company developing RNA technologies to shape the future of gene therapy
Technology:
Rare Genetic Disorders
Headquarters:
Seattle, Washington, United States
Funding Status:
Early Stage Venture
Founded Date:
2018
Estimated Revenue:
$1M to $10M
Industry:
CRISPR-based gene editing